The Canine Stem Cell Therapy Market To Witness An Exponential Satiation In The Next 10 Years The Courier – The Courier

Like all the other verticals, the healthcare vertical is poised to witness an amalgamation of collaborations and networks as a result of the culture of belonging and inclusion being the new DNA therein. Also, remote work arrangements will be simplified with shared services, cloud technologies, and AI is in place. The Canine Stem Cell Therapy Market is meant to capture these happenings and give insights regarding the same.

Read more
The Generate Life Sciences Family of Companies Grows With the Addition of the Cell Care Group of Cord Blood Banks – PRNewswire

This acquisition expands the operational footprint of Generate Life Sciences across three countries, alongside its distribution network for frozen donor gametes in more than 40 countries. In particular, it further increases access to newborn stem cell preservation and genetic screening services across North America. "Generate Life Sciences is the natural partner for Cell Care given our established industry and scientific leadership in our respective markets," says Brent Dennison, Chief Executive Officer of Cell Care

Read more
West Orange Native Educates The Public About Lifesaving Umbilical Cord Donation – TAPinto.net

Beth GoozmanElkis, West Orange native and Group Creative Director at Ogilvy Health Advertising Agency, recently accomplished her 10-year objective of educating the public about donated umbilical cords saving lives. At the end of a woman's pregnancy, herdoctor often hands her a brochure about banking her baby's umbilical cord, as it is rich in stem cells that may help the child or another family member if a health issue arises.

Read more
Century Therapeutics Adds Respected Biotech Executives to Board of Directors – PRNewswire

PHILADELPHIA, June 1, 2021 /PRNewswire/ --Century Therapeutics, a leading cell therapy company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced the appointment of Alessandro Riva, M.D., and Kimberly Blackwell, M.D., as new Independent Directors. A former Executive Vice President at Gilead Sciences and Novartis Pharmaceuticals, Dr.

Read more